Lina Benajiba

14PUBLICATIONS
115CO-AUTHORS
Molecular targetsPredictive and prognostic markersRegenerative medicine (incl. stem cells)Gene and molecular therapyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 08, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|Jul 07, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nabih Maslah, Nina Kaci, Blandine Roux

|Jun 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patients.

Olivier Mansier, Eric Lippert, Lina Benajiba

|Nov 19, 2024
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis.

Damien Luque Paz, Nico Gagelmann, Lina Benajiba

|Oct 30, 2024
Current myeloproliferative neoplasm scoring systems for clinical practice.

Hélène Pasquer, Jean-Jacques Kiladjian, Lina Benajiba

|Apr 19, 2024
INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia Treatment.

Manuela Bratti, Elisa Stubbs, Sergii Kolodych

Pageof 3

Frequent Collaborators

7 joint publications

Bruno Cassinat

5 joint publications

Jean-Jacques Kiladjian

4 joint publications

Alexandre Puissant

4 joint publications

Gabriela Alexe